Company Overview

Bandaram Pharma Packtech Limited (Scrip Code: 524602, ISIN: INE875N01036) filed its FY26 Annual Report and AGM notice, showcasing mixed financial performance with significant growth in consolidated operations but challenges at the standalone level.

Financial Performance

Consolidated Results: Revenue surged 70% to ₹62.92 crore (FY25: ₹36.96 crore), though net profit declined to ₹2.81 lakh (FY25: ₹9.94 lakh). The performance was driven primarily by subsidiary VSR Paper and Packaging, which reported 50% revenue growth to ₹53.13 crore and 82% profit increase to ₹2.06 crore.

Standalone Results: The parent company reported revenue decline to ₹10.96 crore (FY25: ₹12.23 crore) and net loss of ₹1.16 crore (FY25: profit of ₹0.14 crore), reflecting operational challenges in the core business.

Capital Structure & Corporate Actions

The company increased authorized share capital to ₹19.00 crore and issued 5.97 million shares at ₹20 each (including ₹10 premium) through a preferential allotment to acquire 100% of Craftsmart Products Private Limited. This acquisition, valued at ₹11.94 crore, expanded the company's packaging portfolio but contributed to losses of ₹0.46 crore from Craftsmart.

AGM & Governance Matters

The AGM is scheduled for September 24, 2026, to adopt financial statements, reappoint directors including Mr. Bhandaram Premsai Reddy and Mr. Suryaprakasa Rao Bommisetti, and reappoint auditors M.M. Reddy & Co. for a second term.

Auditor Qualification: Statutory auditors issued a qualified opinion regarding VSR Paper's adjustment of ₹12.41 crore trade receivables against payables without sufficient evidence of legal right to set-off, though management maintains transactions were legitimate with nil net impact.

Subsidiary Operations & Financing

Significant investments were made in subsidiaries, including ₹2.00 crore additional investment in VSR Paper and full acquisition of Craftsmart. The company provided corporate guarantees of ₹16.01 crore (FY25: ₹10.17 crore) to Axis Bank for subsidiary credit facilities and had outstanding loans of ₹3.51 crore to director Deepak Reddy Bandaram.

Key Financial Position Changes

  • Assets: Trade receivables increased 67% to ₹31.35 crore; inventories grew 52% to ₹12.94 crore
  • Liabilities: Trade payables surged 273% to ₹16.26 crore; short-term borrowings increased 70% to ₹13.89 crore
  • Capital: Securities premium account recorded ₹5.97 crore from preferential issue

Corporate Governance

Board composition saw several changes during FY26, with multiple director resignations and appointments. The company maintained 7 directors (4 independent) and held 10 board meetings. No dividend was recommended due to absence of profits.